UBS Group
CALC icon

UBS Group’s CalciMedica CALC Stock Holding History

UBS Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16 Hold
3
– – ﹤0.01% 10296
2026
Q1 		$9 Sell
3
-217
-99% -$2.2K ﹤0.01% 10341
2025
Q4 		$7.25K Buy
220
+217
+7,233% +$4.23K ﹤0.01% 8462
2025
Q3 		$52 Sell
3
-3,398
-100% -$48.9K ﹤0.01% 10016
2025
Q2 		$27.2K Buy
3,401
+3,357
+7,630% +$28.8K ﹤0.01% 8231
2025
Q1 		$421 Sell
44
-21
-32% -$262 ﹤0.01% 9785
2024
Q4 		$1.15K Buy
65
+62
+2,067% +$1.09K ﹤0.01% 9300
2024
Q3 		$66 Hold
3
– – ﹤0.01% 9207
2024
Q2 		$59 Hold
3
– – ﹤0.01% 9220
2024
Q1 		$66 Hold
3
– – ﹤0.01% 8892
2023
Q4 		$40 Sell
3
-84
-97% -$1.22K ﹤0.01% 9013
2023
Q3 		$1.16K Buy
87
+84
+2,800% +$1.39K ﹤0.01% 8071
2023
Q2 		$56 Buy
+3
New +$66 ﹤0.01% 8589
2023
Q1 		– Sell
-77
Closed -$2.69K – 9643
2022
Q4 		$2.69K Buy
77
+74
+2,467% +$4.15K ﹤0.01% 9637
2022
Q3 		$0 Sell
3
-225
-99% -$15.9K ﹤0.01% 10362
2022
Q2 		$17K Buy
228
+122
+115% +$8.33K ﹤0.01% 7082
2022
Q1 		$9K Buy
106
+63
+147% +$6K ﹤0.01% 8532
2021
Q4 		$5K Buy
43
+40
+1,333% +$7.77K ﹤0.01% 9377
2021
Q3 		$1K Hold
3
– – ﹤0.01% 9150
2021
Q2 		$1K Sell
3
-26
-90% -$8.53K ﹤0.01% 9128
2021
Q1 		$11K Buy
29
+10
+53% +$15K ﹤0.01% 7848
2020
Q4 		$38K Buy
19
+14
+280% +$20.7K ﹤0.01% 6417
2020
Q3 		$4K Buy
+5
New +$5.21K ﹤0.01% 7392

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group's CALC Position: Q2 2026 in Review

UBS Group held its CalciMedica (CALC) position steady in Q2 2026 at 3 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #10296.

UBS Group first reported a position in CALC in Q3 2020 and has held it in 23 quarters since. The position peaked at $38K in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • UBS Group held 3 shares of CalciMedica worth $16 as of Q2 2026.
  • UBS Group left its CalciMedica share count unchanged in Q2 2026.
  • CalciMedica made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10296 holding.
  • UBS Group first reported a position in CalciMedica in Q3 2020 and has held it in 23 quarters since.
  • UBS Group's CalciMedica position peaked at $38K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.